tirzepatide crohn's disease Mounjaro and Disease: Safety and Considerations GLP-1 with Crohn's Disease: Safety,

and team

KPV appears safe but may cause mild injectionsite irritation or gastrointestinal upset

Of course, thats much better than the one-shot-every-three-months protocol it later changes to

[3] [4] Clinical trials have demonstrated that Rybelsus has cardiovascular safety, making it a valuable option in contemporary diabetes management

Although most studies suggest that GLP-1RAs promote weight loss mainly due to their inhibitory effect on food intake, other central effects that have been described for native GLP-1 and some GLP-1RAs in rodents and humans encourage future clinical trials to explore additional mechanisms that potentially underlie the beneficial effects observed with this drug class